• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PET/CT 评价异基因造血干细胞移植治疗 T 细胞淋巴母细胞淋巴瘤的疗效。

PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma.

机构信息

Department of Hematology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, Shanxi, China.

出版信息

Contrast Media Mol Imaging. 2022 Aug 16;2022:6057017. doi: 10.1155/2022/6057017. eCollection 2022.

DOI:10.1155/2022/6057017
PMID:36072622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9398827/
Abstract

The aim of this study was to investigate the clinical value of positron emission tomography/computerized tomography scanning (PET/CT) in the evaluation of the effect of allogeneic hematopoietic stem cell transplantation in the treatment of T lymphoblastic lymphoma. 12 relevant research articles were collected through layer-by-layer screening in large databases such as Pubmed, Baidu Scholar, and China How Net, and analyzed and summarized using indicators such as progression-free survival (PFS), overall survival (OS), hazard ratio (HR), maximum standardized uptake value (SUV max), total metabolic tumor volume (TMTV), total lesion glycolysis (TLG), elevated lactate dehydrogenase (LDH), and 2-microglobulin (2-MG). The results showed that before treatment, F-FDG PET/CT baseline diagnosis could accurately stage the patients; during treatment, F-FDG PET/CT detection could provide effective treatment information; and after treatment, complications were found during F-FDG PET/CT detection. In summary, F-FDG PET/CT can monitor and evaluate treatment prognosis at baseline, middle, and late stages, and F-FDG PET/CT has become an indispensable and important examination technique in clinical work.

摘要

本研究旨在探讨正电子发射断层扫描/计算机断层扫描(PET/CT)在评估异基因造血干细胞移植治疗 T 淋巴母细胞淋巴瘤效果中的临床价值。通过逐层筛选 Pubmed、百度学术和中国知网等大型数据库,共收集了 12 篇相关研究文章,运用无进展生存(PFS)、总生存(OS)、风险比(HR)、最大标准化摄取值(SUVmax)、总代谢肿瘤体积(TMTV)、总病灶糖酵解(TLG)、乳酸脱氢酶(LDH)升高、β2-微球蛋白(2-MG)等指标进行分析和总结。结果表明,治疗前,F-FDG PET/CT 基线诊断能准确分期;治疗中,F-FDG PET/CT 检测能提供有效的治疗信息;治疗后,F-FDG PET/CT 检测发现并发症。总之,F-FDG PET/CT 能在基线、中期和晚期监测和评估治疗预后,F-FDG PET/CT 已成为临床工作中不可或缺的重要检查技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/ae32c4113e6e/CMMI2022-6057017.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/e34019e75952/CMMI2022-6057017.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/c5f57337e1f6/CMMI2022-6057017.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/467dea1da093/CMMI2022-6057017.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/ae32c4113e6e/CMMI2022-6057017.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/e34019e75952/CMMI2022-6057017.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/c5f57337e1f6/CMMI2022-6057017.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/467dea1da093/CMMI2022-6057017.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8feb/9398827/ae32c4113e6e/CMMI2022-6057017.004.jpg

相似文献

1
PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma.PET/CT 评价异基因造血干细胞移植治疗 T 细胞淋巴母细胞淋巴瘤的疗效。
Contrast Media Mol Imaging. 2022 Aug 16;2022:6057017. doi: 10.1155/2022/6057017. eCollection 2022.
2
Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.移植后氟-18 氟代脱氧葡萄糖正电子发射断层扫描在淋巴细胞性淋巴瘤患者中是一个独立的预后因素,对无进展生存期有影响,但对总生存期没有影响。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211056478. doi: 10.1177/15330338211056478.
3
[Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].[治疗前(18)F-FDG PET-CT代谢参数在晚期结外NK/T细胞淋巴瘤患者中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2019 Nov 23;41(11):831-836. doi: 10.3760/cma.j.issn.0253-3766.2019.11.006.
4
Prognostic value of F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation.FDG PET/CT 对造血干细胞移植前后 T 淋巴母细胞淋巴瘤的预后价值。
Clin Transl Oncol. 2021 Aug;23(8):1571-1576. doi: 10.1007/s12094-021-02551-7. Epub 2021 Jan 15.
5
Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with F-FDG PET/CT, in patients with diffuse large cell B-cell lymphoma.评估 F-FDG PET/CT 计算肿瘤代谢体积的不同方法对弥漫性大 B 细胞淋巴瘤患者的预后价值。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):340-346. doi: 10.1016/j.remn.2020.06.007. Epub 2020 Jul 6.
6
Prognostic value of baseline F-FDG PET/CT metabolic parameters in paediatric lymphoma.基线¹⁸F-FDG PET/CT代谢参数在儿童淋巴瘤中的预后价值
J Med Imaging Radiat Oncol. 2020 Feb;64(1):87-95. doi: 10.1111/1754-9485.12993. Epub 2019 Dec 27.
7
Prognostic Values of Baseline F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma.外周 T 细胞淋巴瘤患者基线 F-FDG PET/CT 的预后价值。
Biomed Res Int. 2020 Feb 25;2020:9746716. doi: 10.1155/2020/9746716. eCollection 2020.
8
Prognostic Impact of Pretreatment 2-[F]-FDG PET/CT Parameters in Primary Gastric DLBCL.原发胃弥漫性大 B 细胞淋巴瘤治疗前 2-[F]-FDG PET/CT 参数的预后影响。
Medicina (Kaunas). 2021 May 14;57(5):498. doi: 10.3390/medicina57050498.
9
Intra-tumor metabolic heterogeneity of gastric cancer on F-FDG PETCT indicates patient survival outcomes.胃癌在F-FDG PETCT上的肿瘤内代谢异质性预示患者生存结局。
Clin Exp Med. 2021 Feb;21(1):129-138. doi: 10.1007/s10238-020-00659-8. Epub 2020 Sep 3.
10
Prognostic role of baseline F-FDG PET/CT parameters in MALT lymphoma.基线 F-FDG PET/CT 参数在 MALT 淋巴瘤中的预后作用。
Hematol Oncol. 2019 Feb;37(1):39-46. doi: 10.1002/hon.2563. Epub 2018 Nov 8.

本文引用的文献

1
Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.移植后氟-18 氟代脱氧葡萄糖正电子发射断层扫描在淋巴细胞性淋巴瘤患者中是一个独立的预后因素,对无进展生存期有影响,但对总生存期没有影响。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211056478. doi: 10.1177/15330338211056478.
2
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker.伴嗜酸性粒细胞增多的髓系/淋巴系肿瘤背景下发生的T细胞淋巴母细胞淋巴瘤:LMO2免疫组化作为一种潜在有用的诊断标志物
Cancers (Basel). 2021 Jun 21;13(12):3102. doi: 10.3390/cancers13123102.
3
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.T细胞淋巴母细胞白血病/淋巴瘤异基因造血干细胞移植的结局:一项单中心研究。
Leuk Res. 2021 Sep;108:106627. doi: 10.1016/j.leukres.2021.106627. Epub 2021 May 18.
4
Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.嵌合抗原受体 T 细胞疗法与移植的整合:CAR T 细胞或基于化疗的完全缓解后异基因造血干细胞移植在 B 细胞急性淋巴细胞白血病中的安全性和长期疗效比较。
Front Immunol. 2021 May 7;12:605766. doi: 10.3389/fimmu.2021.605766. eCollection 2021.
5
Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation.来那度胺对异基因造血干细胞移植后复发或难治性T淋巴细胞母细胞淋巴瘤/白血病的疗效
Leuk Lymphoma. 2021 Oct;62(10):2521-2525. doi: 10.1080/10428194.2021.1919665. Epub 2021 May 17.
6
Prognostic Value of 2-Deoxy-2-[F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores.2-脱氧-2-[F]氟代-D-葡萄糖正电子发射断层扫描/计算机断层扫描使用 Deauville 评分在淋巴瘤自体造血干细胞移植后的预后价值。
Contrast Media Mol Imaging. 2021 Apr 15;2021:5510825. doi: 10.1155/2021/5510825. eCollection 2021.
7
Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(-) Subtype.青少年及成人T细胞淋巴母细胞淋巴瘤免疫亚型的预后价值;超高风险的Pro-T/CD2(-)亚型
Cancers (Basel). 2021 Apr 15;13(8):1911. doi: 10.3390/cancers13081911.
8
Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.异基因造血干细胞移植治疗结外自然杀伤/T 细胞淋巴瘤。
Turk J Haematol. 2021 Jun 1;38(2):126-137. doi: 10.4274/tjh.galenos.2021.2020.0438. Epub 2021 Feb 4.
9
Prognostic value of F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation.FDG PET/CT 对造血干细胞移植前后 T 淋巴母细胞淋巴瘤的预后价值。
Clin Transl Oncol. 2021 Aug;23(8):1571-1576. doi: 10.1007/s12094-021-02551-7. Epub 2021 Jan 15.
10
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.成人T细胞白血病/淋巴瘤合并人嗜T淋巴细胞病毒1型相关脊髓病的异基因造血干细胞移植
Int J Hematol. 2021 May;113(5):765-769. doi: 10.1007/s12185-020-03075-6. Epub 2021 Jan 10.